Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on September 11, 2003; DOI 10.1182/blood-2003-05-1710.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-05-1710v1
103/1/313    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trivedi, P.
Right arrow Articles by Faggioni, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trivedi, P.
Right arrow Articles by Faggioni, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted May 28, 2003
Accepted August 27, 2003

Infection of HHV-8 positive primary effusion lymphoma cells with a recombinant Epstein-Barr virus lead to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression

Pankaj Trivedi*, Kumi Takazawa, Claudia Zompetta, Laura Cuomo, Elena Anastasiadou, Antonino Carbone, Stefania Uccini, Filippo Belardelli, Kenzo Takada, Luigi Frati, and Alberto Faggioni

Department of Experimental Medicine and Pathology, Istituto Pasteur-Fondazione Cenci Bolognetti, University of Rome, Rome, Italy
Department of Tumor Virology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan
Department of Clinical Pathology, San Filippo Neri Hospital, Rome, Italy
Department of Pathology and Scientific Direction, Centro di Riferimento Oncologico, National Cancer Institute, Aviano, Italy
Laboratory of Virology, Istituto Superiore di Sanita, Rome, Italy
Neuromed, INM, Pozzilli, Italy

* Corresponding author; email: pankaj.trivedi{at}uniroma1.it.

To investigate the role of EBV in the pathogenesis of PEL, we infected HHV-8 positive (HHV-8pos) but EBV negative (EBVneg) PEL lines BC-3, CRO-AP/6 and CRO-AP/3 cells with the recombinant Akata EBV strain. All EBV infected clones expressed EBER-1, EBNA-1 and LMP2A. The expression of LMP1 and LMP2B was variable. None however expressed EBNA2-6. The surface markers CD30, CD74 and Syndecan-1 were downregulated in EBV convertants. EBV infected BC-3 and CRO-AP/6 cells were highly tumorigenic in SCID mice in contrast to their respective EBV negative parental cells. However, neither the parental cells nor the virus converted counterparts expressed TCL1. The results showing that PELs upon in vitro EBV infection do not sustain latency III in spite of the absence of immune pressure indicate that the choice of EBV latent gene expression program is cell dependent. The data suggest an important role of EBV in the pathogenesis of PEL.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
A. A. Mack and B. Sugden
EBV Is Necessary for Proliferation of Dually Infected Primary Effusion Lymphoma Cells
Cancer Res., September 1, 2008; 68(17): 6963 - 6968.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. Xu, T. Coleman, J. Zhang, A. Fagot, C. Kotalik, L. Zhao, P. Trivedi, C. Jones, and L. Zhang
Epstein-Barr Virus Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication in Primary Effusion Lymphomas
J. Virol., June 1, 2007; 81(11): 6068 - 6078.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. Boulanger, L. Gerard, J. Gabarre, J.-M. Molina, C. Rapp, J.-F. Abino, J. Cadranel, S. Chevret, and E. Oksenhendler
Prognostic Factors and Outcome of Human Herpesvirus 8-Associated Primary Effusion Lymphoma in Patients With AIDS
J. Clin. Oncol., July 1, 2005; 23(19): 4372 - 4380.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Farina, R. Feederle, S. Raffa, R. Gonnella, R. Santarelli, L. Frati, A. Angeloni, M. R. Torrisi, A. Faggioni, and H.-J. Delecluse
BFRF1 of Epstein-Barr Virus Is Essential for Efficient Primary Viral Envelopment and Egress
J. Virol., March 15, 2005; 79(6): 3703 - 3712.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W. Fan, D. Bubman, A. Chadburn, W. J. Harrington Jr., E. Cesarman, and D. M. Knowles
Distinct Subsets of Primary Effusion Lymphoma Can Be Identified Based on Their Cellular Gene Expression Profile and Viral Association
J. Virol., January 15, 2005; 79(2): 1244 - 1251.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020